Biologic Drug Product CDMO Benchmarking (9th Ed.)

Biologic pharmaceuticals are more popular than ever, and with increasing sponsor demand and project complexity, CDMOs face mounting pressure to stand out in a crowded marketplace.

ISR’s Biologic Drug Product CDMO Benchmarking report reveals how sponsors evaluate providers, what they value, and which CDMOs deliver against expectations. Performance benchmarks and in-depth CDMO profiles highlight where an organization excels, where peers outperform, and opportunities to position strengths more effectively.

What you will learn:

Outsourcing Practices

• Proportion of manufacturing activities outsourced
• Main driver in outsourcing
• Preferred provider usage and management

CDMO Selection Drivers

• Top CDMO selection attributes
• Attributes growing in importance

CDMO Perceptions & Interactions

• CDMO brand familiarity and usage
• Leadership, preference, and proposal volume
• CDMO cost perceptions

CDMO Performance & Competitive Landscape

• How CDMOs measure up to sponsor expectations
• Competitive position across providers

Company Service Quality Profiles

• 20+ CDMO profiles
• Customer feedback on 24 performance metrics
• Overall Satisfaction, Likelihood to Use Again, and Willingness to Recommend

Included Providers:

Companies listed in bold print have a Company Service Quality Profile page detailing company performance based on user ratings (currently using or have used in the past 18 months).

• AbbVie Contract Manufacturing
• Alcami
• Avid Bioservices
• Biovian
• Boehringer Ingelheim BioXcellence
• Bora
• Carbogen Amcis
• Catalent
• Celonic
• Cenexi
• CordenPharma
• Curia
• Enzene
• Famar
• Fareva
• Fujifilm Biotechnologies
• GSK Contract Manufacturing
• Hetero
• IDT Biologika
• Lonza
• MilliporeSigma, including BioReliance
• Next Pharma
• Novartis CDMO (Global Biotech Cooperations)
• Pace Analytical
• Patheon, by ThermoFisher Scientific
• PCI Pharma Services, including Ajinomoto Bio-Pharma Services
• Pfizer CentreOne
• Piramal Pharma Solutions
• Polpharma
• Pyramid Labs
• Recipharm
• Resilience
• Samsung Biologics
• Sandoz
• Siegfried
• Simtra
• Vetter
• Wockhardt
• WuXi Biologics

Respondents were required to pass several screening criteria to qualify and participate in this survey:

• Must work at a biopharmaceutical company
• Must have responsibilities in at least one of the following categories: executive management, R&D management, clinical operations, clinical trial manufacturing, commercial manufacturing, outsourcing/purchasing management, QA/QC, supply chain or validation 
• Must have been involved in outsourced biologic drug product manufacturing within the past 18 months